« Back to Record
Citation APA

Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Lang, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R., Piccart-Gebhart, M., & Cameron, D. A. (2013). CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01). Lancet oncology, 14(3), 244-248. doi:10.1016/S1470-2045(13)70017-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195165

Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Lang, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R., Piccart-Gebhart, M., & Cameron, D. A. (2013). CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01). Lancet oncology, 14(3), 244-248. doi:10.1016/S1470-2045(13)70017-2